(17 days)
Not Found
No
The summary does not mention AI, ML, or any related concepts like image processing, training sets, or performance metrics typically associated with AI/ML algorithms. The description focuses on the mechanical and control aspects of the device.
Yes
The device is described as a "Resuscitation System" and is intended to be used as an "adjunct to manual CPR" to "compress the chest of an adult human" in cases of clinical death, which directly indicates a therapeutic purpose.
No
The device is described as an automated chest compression system, an adjunct to manual CPR, and does not mention any function for diagnosing medical conditions.
No
The device description explicitly states it is a "battery powered device" consisting of a "single use chest compression assembly" and a "reusable platform" containing hardware components like a "drive mechanism" and "power system". This indicates it is a hardware device with integrated software, not a software-only medical device.
Based on the provided information, the AutoPulse Resuscitation System Model 100 is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to provide automated chest compressions as an adjunct to manual CPR on adult patients experiencing clinical death. This is a therapeutic intervention, not a diagnostic one.
- Device Description: The device physically compresses the chest. It does not analyze biological samples (like blood, urine, or tissue) to provide diagnostic information.
- Lack of IVD Indicators: The description does not mention any activities typically associated with IVDs, such as:
- Analyzing samples
- Detecting or measuring substances in the body
- Providing information for diagnosis, monitoring, or screening
Therefore, the AutoPulse Resuscitation System Model 100 falls under the category of a medical device used for treatment/support, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The AutoPulse Resuscitation System Model 100 is intended to be used as an adjunct to manual CPR, on adult patients only, in cases of clinical death as defined by lack of spontaneous breathing and pulse.
Product codes
DRM
Device Description
AutoPulse Resuscitation System Model 100 ("Device") is an automated, portable, battery powered device that compresses the chest of an adult human as an adjunct to manual CPR. The Device consists of a single use chest compression assembly (CCA) that includes a patient liner, and a reusable platform that contains a user control panel, a drive mechanism, a control system, and a power system (rechargeable battery).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
chest
Indicated Patient Age Range
adult patients only
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Appropriate product testing was conducted to evaluate conformance to product specification and substantial equivalence to the predicate device. Testing of the device modifications demonstrates the device meets and improves upon the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
AutoPulse™ Resuscitation System Model 100 K040453
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.5200 External cardiac compressor.
(a)
Identification. An external cardiac compressor is an externally applied prescription device that is electrically, pneumatically, or manually powered and is used to compress the chest periodically in the region of the heart to provide blood flow during cardiac arrest. External cardiac compressor devices are used as an adjunct to manual cardiopulmonary resuscitation (CPR) when effective manual CPR is not possible (e.g., during patient transport or extended CPR when fatigue may prohibit the delivery of effective/consistent compressions to the victim, or when insufficient EMS personnel are available to provide effective CPR).(b)
Classification. Class II (special controls). The special controls for this device are:(1) Nonclinical performance testing under simulated physiological conditions must demonstrate the reliability of the delivery of specific compression depth and rate over the intended duration of use.
(2) Labeling must include the following:
(i) The clinical training necessary for the safe use of this device;
(ii) Adjunctive use only indication prominently displayed on labels physically placed on the device and in any device manuals or other labeling;
(iii) Information on the patient population for which the device has been demonstrated to be effective (including patient size and/or age limitations,
e.g., adult, pediatric and/or infant); and(iv) Information on the time necessary to deploy the device as demonstrated in the performance testing.
(3) For devices that incorporate electrical components, appropriate analysis and testing must demonstrate that the device is electrically safe and electromagnetically compatible in its intended use environment.
(4) Human factors testing and analysis must validate that the device design and labeling are sufficient for effective use by the intended user, including an evaluation for the time necessary to deploy the device.
(5) For devices containing software, software verification, validation, and hazard analysis must be performed.
(6) Components of the device that come into human contact must be demonstrated to be biocompatible.
0
Ka3602
510(k) Summary
General Information
| DEC 21 200 | |
|---|---|
| Classification | Class III |
| Trade Name | AutoPulse™ Resuscitation System Model 100 |
| Common Name | Automatic Mechanical Chest Compressor |
| Classification Name | External Cardiac Compressor 870.5200 |
| Submitter | ZOLL Circulation |
| 249 Humboldt Court | |
| Sunnyvale, CA 94089 | |
| Phone: 408-541-2140 | |
| Fax: 408-514-1030 | |
| Contact | Mark Perkins |
| Director, Quality Assurance and Regulatory Affairs | |
| Date Prepared | October xx, 2006 |
Intended Use
The AutoPulse Resuscitation System Model 100 is intended to be used as an adjunct to manual CPR, on adult patients only, in cases of clinical death as defined by lack of spontaneous breathing and pulse.
Predicate Devices
AutoPulse™ Resuscitation System Model 100 K040453
Device Description
AutoPulse Resuscitation System Model 100 ("Device") is an automated, portable, battery powered device that compresses the chest of an adult human as an adjunct to manual CPR. The Device consists of a single use chest compression assembly (CCA) that includes a patient liner, and a reusable platform that contains a user control panel, a drive mechanism, a control system, and a power system (rechargeable battery).
Materials
1
All materials used in the manufacture of the AutoPulse Resuscitation System Model 100 are suitable for this use and have been used in numerous previously cleared products.
Testing:
Appropriate product testing was conducted to evaluate conformance to product specification and substantial equivalence to the predicate device. Testing of the device modifications demonstrates the device meets and improves upon the predicate device.
Summary of Substantially Equivalence:
The AutoPulse Resuscitation System Model 100 is equivalent to the predicate device. The indications for use, basic overall function, and materials used have been determined to be substantially equivalent.
2
Public Health Service
Image /page/2/Picture/2 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized depiction of an eagle or bird-like figure with three wing-like shapes. The bird is positioned above a circular arrangement of text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA". The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC 2 1 2006
ZOLL Circulation c/o Mr. Mark Perkins Director, Quality Assurance and Regulatory Affairs 249 Humboldt Court Sunnyvale, CA 94089
Re: K063602 AutoPulse™ Resuscitation System Model 100 Regulation Number: 21 CFR 870.5200 Regulation Name: External Cardiac Compressor Regulatory Class: III Product Code: DRM Dated: December 1, 2006 Received: December 5, 2006
Dear Mr. Perkins:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Mark Perkins
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
B. Zimmerman for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
| 510(k) Number (if known): | This Application |
|---|---|
| Device Name: | AutoPulse TM Resuscitation System Model 100 |
| Indications For Use: | The AutoPulse Resuscitation System Model 100 is |
| intended to be used as an adjunct to manual CPR, on adult | |
| patients only, in cases of clinical death as defined by lack | |
| of spontaneous breathing and pulse. |
Prescription Use _X
AND/OR
Over-The-Counter Use
(Part 21 CFR 801 Subpart D)
(21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
のお気になる。
Blymmman
(Division Sign-Off) Division of Cardiovascular Devices 510(k) Number_K063602